glp 1 nausea and vomiting GLP-1 Medications: Understanding How to Manage Side Effects Navigating Nausea While on GLP-1
Description
A doctor can provide guidance on appropriate dosage, dietary support, and potential interactions with other treatments
Health Affairs 2025;44:384-390
Similarly, Mounjaro is FDA-approved for diabetes, while its twin drug Zepbound is approved for obesity
References 1 AvgerinosI.KaragiannisT.MalandrisK.LiakosA.MainouM.BekiariE.et al
Clinical trials and FDA labeling show eructation or burping occurs in approximately 3% of people taking Ozempic injection, up to 2% in people taking Rybelsus (rebranded to Ozempic pill), about 7% of those on Wegovy, and 25% with Mounjaro and Zepbound
doi:10.1002/jac5.1999 Lowe D
